Our Team

James W. Weis

co-Founder & Managing director

James Weis was founding President of the MIT Biotechnology Group and is currently founding CEO of Nest.Bio Labs., a shared incubator space dedicated to supporting life sciences startups, and a Partner at Nest.Bio Ventures, a venture firm that takes a uniquely international and holistic approach to developing, funding, and commercializing next-gen technologies.

Nina Wang

INvestor Relations & Logistics Lead

Nina is a senior in Biological Engineering at MIT. She has been involved in the MIT Media Lab's Community Biotechnology Initiative since 2017 and was previously an officer in the MIT Biotech Group's Investment Initiative. Nina has interned in pharmaceutical R&D and strategy at GSK, and was a 2019 summer analyst at ClearView Healthcare Partners.

Patrick Rivelli

Co-founder & Managing Director

Patrick has been a medical device entrepreneur and investor for over 25 years. He is currently President and CEO of Sonogenix, Inc., a clinical stage medical device company. He was previously founder and CEO of Smart Therapeutics (acquired by Boston Scientific) & Bioabsorbable Therapeutics (acquired by Multi Cell Corporation). He also holds 9 issued patents.

Cami Devoe

Investor Relations & PR Lead

Cami is a senior in Biology and Computer Science at MIT. She has been involved with the group Angels group since 2018 and with the MIT Biotech Group (MBG) since 2017. Cami has worked with New England Biolabs developing NGS tools, .406 Ventures, and in this past summer worked as an analyst within the Life Sciences sector of Navigant.

Phoebe Spear

Director

Phoebe is a junior in Computer Science at MIT, and was previously a director of the investment initiative of the MIT Biotech Group (MBG), and has been part of the group since 2017. She worked in immunology research at the Irvine Lab in the Koch Institute for Integrative Cancer Research at MIT and as a data scientist at Optum, a healthcare information technology firm.

Kristen Overly

Advisor

Kristen Overly is a senior in Biological Engineering at MIT. She has served as the Undergraduate President of the MIT Biotech Group, and was previously a director of the Angels group. She consulted for Remora Therapeutics, worked on JPMorgan Chase’s Healthcare Equity Capital Markets team, and will be joining Back Bay Life Sciences.